Overview

LP-PLA2 is an enzyme primarily found in low-density lipoprotein (LDL) particles, also known as "bad cholesterol." It plays a role in the breakdown of phospholipids in the blood and has been associated with the development of atherosclerosis. Elevated levels of LP-PLA2 can indicate increased inflammation in the blood vessels, a key contributor to the formation of plaques in the arteries.

Risk Assessment

The LP-PLA2 test is primarily used to assess cardiovascular risk, including the likelihood of:

• Atherosclerosis (narrowing of the arteries due to plaque buildup)
• Heart disease
• Stroke

An elevated level of LP-PLA2 in the blood suggests higher inflammation in the arteries, which increases the risk for cardiovascular events such as heart attacks and strokes. It is particularly useful when other risk factors, such as high cholesterol or high blood pressure, are present but may not fully explain a patient's risk.

Normal Range

The normal range for LP-PLA2 varies slightly between laboratories, but generally:

• < 200 ng/mL: Normal
• 200-400 ng/mL: Borderline or elevated risk
• > 400 ng/mL: High risk of cardiovascular events.

Interpretation

• Low levels of LP-PLA2: Generally indicate a lower risk of cardiovascular events.
• Moderate levels of LP-PLA2: Suggest a moderate risk, requiring further evaluation and possibly lifestyle changes or treatment.
• High levels of LP-PLA2: Indicate a higher risk of cardiovascular diseases, including heart attack, stroke, and peripheral artery disease. This may prompt further testing, closer monitoring, or medication to reduce inflammation and manage risk factors.

Sample Type

The sample required for the LP-PLA2 test is typically a blood sample, which is collected via venipuncture (a needle inserted into a vein) from your arm. The blood is then analyzed for the presence of LP-PLA2 enzyme levels.